Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers

Background: Preexisting immunity to SARS-CoV-2 could be related to cross-reactive antibodies to common human-coronaviruses (HCoVs). This study aimed to evaluate whether human milk antibodies against to S1 and S2 subunits SARS-CoV-2 are cross-reactive to S1 and S2 subunits HCoV-OC43 and HCoV-229E in...

Full description

Bibliographic Details
Main Authors: Veronique Demers-Mathieu, Ciera DaPra, Gabrielle Mathijssen, David A. Sela, Kirsi M. Jarvinen, Antti Seppo, Shawn Fels, Elena Medo
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/4/1749
id doaj-afd4486f737d492b9b442bcff6ef9e6e
record_format Article
spelling doaj-afd4486f737d492b9b442bcff6ef9e6e2021-02-10T00:06:57ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-02-01221749174910.3390/ijms22041749Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed MothersVeronique Demers-Mathieu0Ciera DaPra1Gabrielle Mathijssen2David A. Sela3Kirsi M. Jarvinen4Antti Seppo5Shawn Fels6Elena Medo7Department of Neonatal Immunology and Microbiology, Medolac Laboratories A Public Benefit Corporation, Boulder City, NV 89005, USADepartment of Neonatal Immunology and Microbiology, Medolac Laboratories A Public Benefit Corporation, Boulder City, NV 89005, USADepartment of Neonatal Immunology and Microbiology, Medolac Laboratories A Public Benefit Corporation, Boulder City, NV 89005, USADepartment of Food Science, University of Massachusetts Amherst, Amherst, MA 01003, USAMedical Center, Department of Pediatrics, Pediatric Allergy/Immunology, University of Rochester, Rochester, NY 14642, USAMedical Center, Department of Pediatrics, Pediatric Allergy/Immunology, University of Rochester, Rochester, NY 14642, USADepartment of Neonatal Immunology and Microbiology, Medolac Laboratories A Public Benefit Corporation, Boulder City, NV 89005, USADepartment of Neonatal Immunology and Microbiology, Medolac Laboratories A Public Benefit Corporation, Boulder City, NV 89005, USABackground: Preexisting immunity to SARS-CoV-2 could be related to cross-reactive antibodies to common human-coronaviruses (HCoVs). This study aimed to evaluate whether human milk antibodies against to S1 and S2 subunits SARS-CoV-2 are cross-reactive to S1 and S2 subunits HCoV-OC43 and HCoV-229E in mothers with a confirmed COVID-19 PCR test, in mothers with previous viral symptoms during COVID-19 pandemic, and in unexposed mothers; Methods: The levels of secretory IgA (SIgA)/IgA, secretory IgM (SIgM)/IgM, and IgG specific to S1 and S2 SARS-CoV-2, and reactive to S1 + S2 HCoV-OC43, and HCoV-229E were measured in milk from 7 mothers with a confirmed COVID-19 PCR test, 20 mothers with viral symptoms, and unexposed mothers (6 Ctl1-2018 and 16 Ctl2-2018) using ELISA; Results: The S2 SARS-CoV-2 IgG levels were higher in the COVID-19 PCR (<i>p </i>= 0.014) and viral symptom (<i>p</i> = 0.040) groups than in the Ctl1-2018 group. We detected a higher number of positive correlations between the antigens and secretory antibodies in the COVID-19 PCR group than in the viral symptom and Ctl-2018 groups. S1 + S2 HCoV-OC43-reactive IgG was higher in the COVID-19 group than in the control group (<i>p</i> = 0.002) but did not differ for the other antibodies; Conclusions: Mothers with a confirmed COVID-19 PCR and mothers with previous viral symptoms had preexisting human milk antibodies against S2 subunit SARS-CoV-2. Human milk IgG were more specific to S2 subunit SARS-CoV-2 than other antibodies, whereas SIgA and SIgM were polyreactive and cross-reactive to S1 or S2 subunit SARS-CoV-2.https://www.mdpi.com/1422-0067/22/4/1749breast milkpassive immunityimmunoglobulinsinfectious diseasesbreastfeedingpolyreactive antibody
collection DOAJ
language English
format Article
sources DOAJ
author Veronique Demers-Mathieu
Ciera DaPra
Gabrielle Mathijssen
David A. Sela
Kirsi M. Jarvinen
Antti Seppo
Shawn Fels
Elena Medo
spellingShingle Veronique Demers-Mathieu
Ciera DaPra
Gabrielle Mathijssen
David A. Sela
Kirsi M. Jarvinen
Antti Seppo
Shawn Fels
Elena Medo
Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers
International Journal of Molecular Sciences
breast milk
passive immunity
immunoglobulins
infectious diseases
breastfeeding
polyreactive antibody
author_facet Veronique Demers-Mathieu
Ciera DaPra
Gabrielle Mathijssen
David A. Sela
Kirsi M. Jarvinen
Antti Seppo
Shawn Fels
Elena Medo
author_sort Veronique Demers-Mathieu
title Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers
title_short Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers
title_full Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers
title_fullStr Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers
title_full_unstemmed Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers
title_sort human milk antibodies against s1 and s2 subunits from sars-cov-2, hcov-oc43, and hcov-229e in mothers with a confirmed covid-19 pcr, viral symptoms, and unexposed mothers
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-02-01
description Background: Preexisting immunity to SARS-CoV-2 could be related to cross-reactive antibodies to common human-coronaviruses (HCoVs). This study aimed to evaluate whether human milk antibodies against to S1 and S2 subunits SARS-CoV-2 are cross-reactive to S1 and S2 subunits HCoV-OC43 and HCoV-229E in mothers with a confirmed COVID-19 PCR test, in mothers with previous viral symptoms during COVID-19 pandemic, and in unexposed mothers; Methods: The levels of secretory IgA (SIgA)/IgA, secretory IgM (SIgM)/IgM, and IgG specific to S1 and S2 SARS-CoV-2, and reactive to S1 + S2 HCoV-OC43, and HCoV-229E were measured in milk from 7 mothers with a confirmed COVID-19 PCR test, 20 mothers with viral symptoms, and unexposed mothers (6 Ctl1-2018 and 16 Ctl2-2018) using ELISA; Results: The S2 SARS-CoV-2 IgG levels were higher in the COVID-19 PCR (<i>p </i>= 0.014) and viral symptom (<i>p</i> = 0.040) groups than in the Ctl1-2018 group. We detected a higher number of positive correlations between the antigens and secretory antibodies in the COVID-19 PCR group than in the viral symptom and Ctl-2018 groups. S1 + S2 HCoV-OC43-reactive IgG was higher in the COVID-19 group than in the control group (<i>p</i> = 0.002) but did not differ for the other antibodies; Conclusions: Mothers with a confirmed COVID-19 PCR and mothers with previous viral symptoms had preexisting human milk antibodies against S2 subunit SARS-CoV-2. Human milk IgG were more specific to S2 subunit SARS-CoV-2 than other antibodies, whereas SIgA and SIgM were polyreactive and cross-reactive to S1 or S2 subunit SARS-CoV-2.
topic breast milk
passive immunity
immunoglobulins
infectious diseases
breastfeeding
polyreactive antibody
url https://www.mdpi.com/1422-0067/22/4/1749
work_keys_str_mv AT veroniquedemersmathieu humanmilkantibodiesagainsts1ands2subunitsfromsarscov2hcovoc43andhcov229einmotherswithaconfirmedcovid19pcrviralsymptomsandunexposedmothers
AT cieradapra humanmilkantibodiesagainsts1ands2subunitsfromsarscov2hcovoc43andhcov229einmotherswithaconfirmedcovid19pcrviralsymptomsandunexposedmothers
AT gabriellemathijssen humanmilkantibodiesagainsts1ands2subunitsfromsarscov2hcovoc43andhcov229einmotherswithaconfirmedcovid19pcrviralsymptomsandunexposedmothers
AT davidasela humanmilkantibodiesagainsts1ands2subunitsfromsarscov2hcovoc43andhcov229einmotherswithaconfirmedcovid19pcrviralsymptomsandunexposedmothers
AT kirsimjarvinen humanmilkantibodiesagainsts1ands2subunitsfromsarscov2hcovoc43andhcov229einmotherswithaconfirmedcovid19pcrviralsymptomsandunexposedmothers
AT anttiseppo humanmilkantibodiesagainsts1ands2subunitsfromsarscov2hcovoc43andhcov229einmotherswithaconfirmedcovid19pcrviralsymptomsandunexposedmothers
AT shawnfels humanmilkantibodiesagainsts1ands2subunitsfromsarscov2hcovoc43andhcov229einmotherswithaconfirmedcovid19pcrviralsymptomsandunexposedmothers
AT elenamedo humanmilkantibodiesagainsts1ands2subunitsfromsarscov2hcovoc43andhcov229einmotherswithaconfirmedcovid19pcrviralsymptomsandunexposedmothers
_version_ 1724275697676976128